Global Biochips Market Size Study, By Product, By Application, By End User and Regional Forecasts 2022-2032

Description

The Global Biochips Market is valued at approximately USD 17.09 billion in 2023 and is expected to grow with a robust CAGR of 11.2% over the forecast period 2024-2032. Biochips, as miniaturized medical devices, play a critical role in molecular laboratories by enabling simultaneous biochemical reactions, which have broad applications, from disease diagnosis to the detection of hazardous biological agents. These devices, built on microarray and microfluidic technologies, have gained considerable traction in the biomedical field due to their efficiency in screening numerous biological analytes swiftly. Notably, the digital microfluidic biochip has emerged as a highly efficient tool within this domain, underpinning significant advancements in biochemical applications.

The Global Biochips Market is witnessing substantial growth, driven by an increase in the prevalence of cancer, immunological disorders, and viral infections. The rise in the geriatric population, coupled with the expanding number of biochip applications and the growing adoption of personalized medicine, further propels market expansion. However, the high costs associated with biochip technology and a lack of awareness, particularly in emerging economies, pose challenges to market growth. On the positive side, increased R&D investments and government funding, coupled with untapped potential in emerging markets, are expected to offer lucrative opportunities for industry stakeholders in the coming years.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. In 2023, North America dominated the market, supported by its advanced healthcare infrastructure and early adoption of biochip technologies. Europe followed closely, driven by its strong research and development activities in biotechnology. Meanwhile, the Asia-Pacific region is projected to witness the highest growth rate during the forecast period, attributed to its large population base, increasing disposable income, and growing patient awareness about biochips and their applications.

Major market players included in this report are:

Illumina, Inc.
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Randox Laboratories Ltd.
Fluidigm Corporation
PerkinElmer, Inc.
QIAGEN N.V.
HORIBA, Ltd.
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Micronit Microfluidics BV
OriGene Technologies, Inc.
ANALIS SA/NV
AMS Alliance
Dynamic Biosensors GmbH

The detailed segments and sub-segments of the market are explained below:

By Product:

DNA Chip
Protein Chip
Lab-on-a-chip
Others

By Application:

Drug Discovery & Development
Disease Diagnostics
Genomics
Proteomics
Agriculture
Other Applications

By End User:

Biotechnology and Pharmaceutical Companies
Hospitals & Diagnostics Centers
Academic & Research Institutes
Other End Users

By Region:

North America:

U.S.
Canada

Europe:

Germany
France
UK
Italy
Spain
Rest of Europe

Asia Pacific:

Japan
China
India
Australia
South Korea
Rest of Asia Pacific

Latin America:

Brazil
Mexico
Rest of Latin America
Middle East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of the geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Biochips Market Executive Summary

1.1. Global Biochips Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Application
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biochips Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Biochips Market Dynamics

3.1. Market Drivers
- 3.1.1. Increase in Prevalence of Cancer and Genetic Disorders
- 3.1.2. Rise in Adoption of Personalized Medicine
3.2. Market Challenges
- 3.2.1. High Cost of Biochip Technology
- 3.2.2. Lack of Awareness in Emerging Economies
3.3. Market Opportunities
- 3.3.1. Growing R&D Investments
- 3.3.2. Expanding Applications in Untapped Markets
- 3.3.3. Government Funding and Support

Chapter 4. Global Biochips Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biochips Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. DNA Chip
5.3. Protein Chip
5.4. Lab-on-a-chip
5.5. Others

Chapter 6. Global Biochips Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Biochips Market: Drug Discovery & Development Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.3. Global Biochips Market: Disease Diagnostics Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.4. Genomics
6.5. Proteomics
6.6. Agriculture
6.7. Other Applications

Chapter 7. Global Biochips Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Biotechnology and Pharmaceutical
7.3.Hospitals & Diagnostics Centers
7.4. Academic & Research Institutes
7.5. Other End Users

Chapter 8. Global Biochips Market Size & Forecasts by Region 2022-2032

8.1. North America Biochips Market
- 8.1.1. U.S. Biochips Market
  - 8.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Application breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Biochips Market
8.2. Europe Biochips Market
- 8.2.1. Germany Biochips Market
- 8.2.2. France Biochips Market
- 8.2.3. UK Biochips Market
- 8.2.4. Italy Biochips Market
- 8.2.5. Spain Biochips Market
- 8.2.6. Rest of Europe Biochips Market
8.3. Asia-Pacific Biochips Market
- 8.3.1. China Biochips Market
- 8.3.2. Japan Biochips Market
- 8.3.3. India Biochips Market
- 8.3.4. Australia Biochips Market
- 8.3.5. South Korea Biochips Market
- 8.3.6. Rest of Asia Pacific Biochips Market
8.4. Latin America Biochips Market
- 8.4.1. Brazil Biochips Market
- 8.4.2. Mexico Biochips Market
- 8.4.3. Rest of Latin America Biochips Market
8.5. Middle East and Africa Biochips Market
- 8.5.1. Saudi Arabia Biochips Market
- 8.5.2. South Africa Biochips Market
- 8.5.3. Rest of Middle East and Africa Biochips Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Illumina, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. bioMerieux S.A.
- 9.3.3. Bio-Rad Laboratories, Inc.
- 9.3.4. Randox Laboratories Ltd.
- 9.3.5. Fluidigm Corporation
- 9.3.6. PerkinElmer, Inc.
- 9.3.7. QIAGEN N.V.
- 9.3.8. HORIBA, Ltd.
- 9.3.9. F. Hoffmann-La Roche Ltd.
- 9.3.10. Thermo Fisher Scientific Inc.
- 9.3.11. Micronit Microfluidics BV
- 9.3.12. OriGene Technologies, Inc.
- 9.3.13. ANALIS SA/NV
- 9.3.14. AMS Alliance
- 9.3.15. Dynamic Biosensors GmbH

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes